Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Louis

Showing results (561-570 of 576) with videos related to

Pageof 58
Sort By:
NPJ Vaccines|September 5, 2019
Interrogation of a live-attenuated enterotoxigenic <i>Escherichia coli</i> vaccine highlights features unique to wild-type infectionSubhra Chakraborty, Arlo Randall, Tim J Vickers, et al.
The Journal of Infectious Diseases|May 26, 2018
Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine DevelopmentSubhra Chakraborty, Arlo Randall, Tim J Vickers, et al.
Physics of Life Reviews|May 31, 2022
The long and winding road to understanding organismal construction: Reply to comments on "From genotypes to organisms: State-of-the-art and perspectives of a cornerstone in evolutionary dynamics"Susanna Manrubia, José A Cuesta, Jacobo Aguirre, et al.
The Lancet. Infectious Diseases|November 24, 2019
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trialFirdausi Qadri, Marjahan Akhtar, Taufiqur R Bhuiyan, et al.
Physics of Life Reviews|June 5, 2021
From genotypes to organisms: State-of-the-art and perspectives of a cornerstone in evolutionary dynamicsSusanna Manrubia, José A Cuesta, Jacobo Aguirre, et al.
Vaccine|November 30, 2023
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshopsShahida Baqar, Aurelio Bonavia, A Louis Bourgeois, et al.
Vaccine|November 29, 2023
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentationsSoumalya Banerjee, Eileen M Barry, Shahida Baqar, et al.
Vaccine|November 27, 2018
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analysesMarjahan Akhtar, Mohiul I Chowdhury, Taufiqur R Bhuiyan, et al.
Scientific Reports|July 6, 2022
Noninvasive prenatal diagnosis of genetic diseases induced by triplet repeat expansion by linked read haplotyping and Bayesian approachC Liautard-Haag, G Durif, C VanGoethem, et al.
Chest|November 14, 2006
Feasibility of retinoids for the treatment of emphysema studyMichael D Roth, John E Connett, Jeanine M D'Armiento, et al.
Pageof 58

Showing results (561-570 of 576) with videos related to

Sort By:
Pageof 58
NPJ Vaccines|September 5, 2019
Interrogation of a live-attenuated enterotoxigenic <i>Escherichia coli</i> vaccine highlights features unique to wild-type infectionSubhra Chakraborty, Arlo Randall, Tim J Vickers, et al.
The Journal of Infectious Diseases|May 26, 2018
Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine DevelopmentSubhra Chakraborty, Arlo Randall, Tim J Vickers, et al.
Physics of Life Reviews|May 31, 2022
The long and winding road to understanding organismal construction: Reply to comments on "From genotypes to organisms: State-of-the-art and perspectives of a cornerstone in evolutionary dynamics"Susanna Manrubia, José A Cuesta, Jacobo Aguirre, et al.
The Lancet. Infectious Diseases|November 24, 2019
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trialFirdausi Qadri, Marjahan Akhtar, Taufiqur R Bhuiyan, et al.
Physics of Life Reviews|June 5, 2021
From genotypes to organisms: State-of-the-art and perspectives of a cornerstone in evolutionary dynamicsSusanna Manrubia, José A Cuesta, Jacobo Aguirre, et al.
Vaccine|November 30, 2023
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshopsShahida Baqar, Aurelio Bonavia, A Louis Bourgeois, et al.
Vaccine|November 29, 2023
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentationsSoumalya Banerjee, Eileen M Barry, Shahida Baqar, et al.
Vaccine|November 27, 2018
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analysesMarjahan Akhtar, Mohiul I Chowdhury, Taufiqur R Bhuiyan, et al.
Scientific Reports|July 6, 2022
Noninvasive prenatal diagnosis of genetic diseases induced by triplet repeat expansion by linked read haplotyping and Bayesian approachC Liautard-Haag, G Durif, C VanGoethem, et al.
Chest|November 14, 2006
Feasibility of retinoids for the treatment of emphysema studyMichael D Roth, John E Connett, Jeanine M D'Armiento, et al.
Pageof 58